LAKSHMIPATHI VADLAKONDA

Prof. LAKSHMIPATHI VADLAKONDA

Retired Professor from Kakatiya University, Warangal, Telangana (State)< India 506009
+1

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
LVLAKSHMIPATHI VADLAKONDA
LAKSHMIPATHI VADLAKONDA
MPMukesh Pasupuleti
Mukesh Pasupuleti
RPReddanna Pallu
Reddanna Pallu
The PI3K–Akt pathway together with one of its downstream targets, the mechanistic target of rapamycin (mTOR) is a highly deregulated pathway in cancers. There is a reciprocal relation between the Akt phosphorylation and mTOR complexes. Akt phosphorylated at T308 activates mTORC1 by inhibition of the tuberous sclerosis complex (TSC1/2), where as mTORC2 is recognized as the kinase that phosphorylates Akt at S473. Recent developments in the research on regulatory mechanisms of autophagy places mTORC1 mediated inhibition of autophagy at the central position in activation of proliferation and survival pathways in cells. Autophagy is a negative regulator of Wnt signaling pathway and the downstream effectors of Wnt signaling pathway, cyclin D1 and the c-Myc, are the key players in initiation of cell cycle and regulation of the G1-S transition in cancer cells. Production of reaction oxygen species (ROS), a common feature of a cancer cell metabolism, activates several downstream targets like the transcription factors FoxO, which play key roles in promoting the progression of cell cycle. A model is presented on the role of PI3K -Akt - mTOR and Wnt pathways in regulation of the progression of cell cycle through Go-G1-and S phases.

1 January 2013 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
LVLAKSHMIPATHI VADLAKONDA
LAKSHMIPATHI VADLAKONDA
ADAbhinandita Dash
Abhinandita Dash
MPMukesh Pasupuleti
Mukesh Pasupuleti
KKKotha Anil Kumar
Kotha Anil Kumar
PRPallu Reddanna
Pallu Reddanna
The serine threonine protein kinase, Akt, is at the central hub of signaling pathways that regulates cell growth, differentiation, and survival. The reciprocal relation that exists between the two activating phosphorylation sites of Akt, T308 and S473, and the two mTOR complexes, C1 and C2, forms the central controlling hub that regulates these cellular functions. In our previous review “PI3Kinase (PI3K)-AKT-mTOR and Wnt signaling pathways in cell cycle” we discussed the reciprocal relation between mTORC1 and C2 complexes in regulating cell metabolism and cell cycle progression in cancer cells. We present in this article, a hypothesis that activation of Akt-T308 phosphorylation in the presence of high ATP:AMP ratio promotes the stability of its phosphorylations and activates mTORC1 and the energy consuming biosynthetic processes. Depletion of energy leads to inactivation of mTORC1, activation of AMPK, FoxO, and promotes constitution of mTORC2 that leads to phosphorylation of Akt S473. Akt can also be activated independent of PI3K; this appears to have an advantage under situations like dietary restrictions, where insulin/insulin growth factor signaling could be a casualty.

8 November 2016 in Current Drug Targets
Verified
Journal Article
Closed access
NYNagendra Yarla
Nagendra Yarla
Anupam BishayeeAnupam Bishayee
Anupam Bishayee
LVLAKSHMIPATHI VADLAKONDA
LAKSHMIPATHI VADLAKONDA
RCRamakrishna Chintala
Ramakrishna Chintala
GDGovinda Duddukuri
Govinda Duddukuri
KDKaladhar Dowluru
Kaladhar Dowluru
Phospholipase A2s (PLA2s) are group of enzymes, which cleave phospholipids specifically at sn-2 position to liberate free fatty acid, mostly arachidonic acid (AA) and lysophospholipids (LPLs). Inhibition of PLA2 prevents the liberation of AA and LPLs. Hence, researchers have been considering PLA2s could be a better therapeutic target than the downstream enzymes cyclooxygense and lipoxygenase. Several isoforms of PLA2s exist; they are mainly divided into secretory PLA2s (sPLA2), cytosolic PLA2s (cPLA2), and calcium independent PLA2s (iPLA2), platelet activating factor- acyl hydrolase (PAF-AH), lysosomal PLA2 (LPLA2), adipose-specific PLA2 (Ad- PLA). Each isoform of PLA2s is different in its chemical structure and physiological functions. sPLA2s (Groups IIA, V and X) are well characterized as proinflammatory mediating enzymes but their role in cancer is controversial. Groups IVA, IVB and IVC cPLA2s are present in humans but only Group IVA cPLA2 plays key role in pathophysiology of various cancers and inflammation. The role of iPLA2 in inflammation and cancer is limited. Lipoprotein associated PLA2 (Group VIIA PLA2), a PAF-AH isoform, has key role in atherosclerosis. Several isoform specific PLA2 inhibitors have been developed and some of the PLA2s inhibitors are currently under clinical trials for various inflammatory and oncologic diseases. This review focuses on the recent experimental evidences to support the notion that PLA2s are causally implicated in the pathobiology of cancer and inflammatory related disorders and discuss the potential utility of isoform specific PLA2 inhibitors as preventive and/or therapeutic agents.

11 February 2015 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
KKKalyani Korla
Kalyani Korla
LVLAKSHMIPATHI VADLAKONDA
LAKSHMIPATHI VADLAKONDA
CMChanchal K. Mitra
Chanchal K. Mitra
In the present work, we have kinetically simulated two mitochondrial shuttles, malate-aspartate shuttle (used for transferring reducing equivalents) and citrate-pyruvate shuttle (used for transferring carbon skeletons). However, the functions of these shuttles are not limited to the points mentioned above, and they can be used in different arrangements to meet different cellular requirements. Both the shuttles are intricately associated with Krebs cycle through the metabolites involved. The study of this system of shuttles and Krebs cycle explores the response of the system in different metabolic environments. Here, we have simulated these subsets individually and then combined them to study the interactions among them and to bring out the dynamics of these pathways in focus. Four antiports and a pyruvate pump were modelled along with the metabolic reactions on both sides of the inner mitochondrial membrane. Michaelis-Menten approach was extended for deriving rate equations of every component of the system. Kinetic simulation was carried out using ordinary differential equation solver in GNU Octave. It was observed that all the components attained steady state, sooner or later, depending on the system conditions. Progress curves and phase plots were plotted to understand the steady state behaviour of the metabolites involved. A comparative analysis between experimental and simulated data show fair agreement thus validating the usefulness and applicability of the model.

1 January 2013 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
LVLAKSHMIPATHI VADLAKONDA
LAKSHMIPATHI VADLAKONDA
ADAbhinandita Dash
Abhinandita Dash
MPMukesh Pasupuleti
Mukesh Pasupuleti
KKKotha Anil Kumar
Kotha Anil Kumar
PRPallu Reddanna
Pallu Reddanna

19 August 2020 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
LVLAKSHMIPATHI VADLAKONDA
LAKSHMIPATHI VADLAKONDA
MIMeera Indracanti
Meera Indracanti
SKSuresh K. Kalangi
Suresh K. Kalangi
MBMeher Gayatri Bolisetti
Meher Gayatri Bolisetti
NNNavya G Naidu
Navya G Naidu
ARAramati B. M. Reddy
Aramati B. M. Reddy